Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA As Actionable Targets in Triple-Negative Breast Cancer. Bangla J Med Phys 2025, 16 (2), 56-64. https://doi.org/10.3329/bjmp.v16i2.84807.